Loading...
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
BACKGROUND: Efficacy and safety profiles by sex and age (6-9 vs 10-12 years) and magnitude and duration of effect by effect size overall and across the day of lisdexamfetamine dimesylate (LDX) vs placebo were assessed. METHODS: This study enrolled children (6-12 years) with attention-deficit/hyperac...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3022598/ https://ncbi.nlm.nih.gov/pubmed/21156071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1753-2000-4-32 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|